Metformin for Weight Loss in Schizophrenia

Stopped early · Not applicable

Conditions studied: Schizophrenia, Obesity

In brief

Study hypothesis is that patients on antipsychotics medication treated with metformin will show loss in weight and improved measures of glucose metabolism.

Key facts

Study ID

NCT01177709

Run by

Nathan Kline Institute for Psychiatric Research

People needed

12

Starts

2008-05-01

Expected to finish

2011-04-01

Last updated by the study team

2017-09-01

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients will be 18-70 years of age;
• Currently hospitalized or an outpatient at MPC;
• BMI ≥ 35 or excessive recent weight gain ( > than 10 lb weight gain in the past 3 months);
• Patients will have a diagnosis of schizophrenia or schizoaffective disorder or bipolar disorder.

You may not qualify if…

• Age below 18 or over 70;
• Patient is currently already treated with metformin.

Where it is running

• Manhatan Psychiatric Center — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.